About
Technology
Issues
FAQ
Links
Official Page
Comparable
COVID
‐19 outcomes with current use of
GLP
‐1 receptor agonists,
DPP
‐4 inhibitors or
SGLT
‐2 inhibitors among patients with diabetes who tested positive for
SARS‐CoV
‐2
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.